336 related articles for article (PubMed ID: 30104116)
21. Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus (ILTV) and protective immunity.
Sabir AJ; Adams TE; O'Rourke D; Devlin JM; Noormohammadi AH
Vet Microbiol; 2019 Jan; 228():252-258. PubMed ID: 30593375
[TBL] [Abstract][Full Text] [Related]
22. Attenuation and Protection Efficacy of a Recombinant Infectious Laryngotracheitis Virus (ILTV) Depleted of Open Reading Frame C (ΔORFC) when Delivered in ovo.
Schneiders GH; Riblet SM; García M
Avian Dis; 2018 Jun; 62(2):143-151. PubMed ID: 29944395
[TBL] [Abstract][Full Text] [Related]
23. The route of inoculation dictates the replication patterns of the infectious laryngotracheitis virus (ILTV) pathogenic strain and chicken embryo origin (CEO) vaccine.
Beltrán G; Williams SM; Zavala G; Guy JS; García M
Avian Pathol; 2017 Dec; 46(6):585-593. PubMed ID: 28532159
[TBL] [Abstract][Full Text] [Related]
24. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
Vagnozzi A; García M; Riblet SM; Zavala G
Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
[TBL] [Abstract][Full Text] [Related]
25. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
[TBL] [Abstract][Full Text] [Related]
26. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
Devlin JM; Browning GF; Hartley CA; Gilkerson JR
Vaccine; 2007 May; 25(18):3561-6. PubMed ID: 17316926
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of vaccination against infectious laryngotracheitis (ILT) with recombinant herpesvirus of turkey (rHVT-LT) and chicken embryo origin (CEO) vaccines applied alone or in combination.
Maekawa D; Riblet SM; Newman L; Koopman R; Barbosa T; García M
Avian Pathol; 2019 Dec; 48(6):573-581. PubMed ID: 31304770
[TBL] [Abstract][Full Text] [Related]
28. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
[TBL] [Abstract][Full Text] [Related]
29. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
Mashchenko A; Riblet SM; Zavala G; García M
Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
[TBL] [Abstract][Full Text] [Related]
30. Superinfection and recombination of infectious laryngotracheitis virus vaccines in the natural host.
Fakhri O; Devlin JM; Browning GF; Coppo MJC; Quinteros JA; Diaz-Méndez A; Lee SW; Hartley CA
Vaccine; 2020 Nov; 38(47):7508-7516. PubMed ID: 33012604
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
Rodríguez-Avila A; Oldoni I; Riblet S; Garcia M
Avian Pathol; 2008 Jun; 37(3):287-92. PubMed ID: 18568655
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
[TBL] [Abstract][Full Text] [Related]
33. Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host.
Loncoman CA; Hartley CA; Coppo MJ; Vaz PK; Diaz-Méndez A; Browning GF; Lee SW; Devlin JM
PLoS One; 2017; 12(3):e0174590. PubMed ID: 28350819
[TBL] [Abstract][Full Text] [Related]
34. Persistence and spreading of field and vaccine strains of infectious laryngotracheitis virus (ILTV) in vaccinated and unvaccinated geographic regions, in Brazil.
Chacón JL; Núñez LF; Vejarano MP; Parra SH; Astolfi-Ferreira CS; Ferreira AJ
Trop Anim Health Prod; 2015 Aug; 47(6):1101-8. PubMed ID: 25904510
[TBL] [Abstract][Full Text] [Related]
35. Protection Efficacy of the Infectious Laryngotracheitis (ILT) Serva CEO Vaccine Strain in Broiler Chickens Under Different Vaccination Coverage Conditions.
Assen AM; Gerber PF; Walkden-Brown SW
Avian Dis; 2023 Jun; 67(2):160-169. PubMed ID: 37556295
[TBL] [Abstract][Full Text] [Related]
36. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens.
Vagnozzi A; Zavala G; Riblet SM; Mundt A; García M
Avian Pathol; 2012; 41(1):21-31. PubMed ID: 22845318
[TBL] [Abstract][Full Text] [Related]
37. Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines.
Rodríguez-Avila A; Oldoni I; Riblet S; García M
Avian Dis; 2007 Dec; 51(4):905-11. PubMed ID: 18251401
[TBL] [Abstract][Full Text] [Related]
38. Spread of the newly emerging infectious laryngotracheitis viruses in Australia.
Agnew-Crumpton R; Vaz PK; Devlin JM; O'Rourke D; Blacker-Smith HP; Konsak-Ilievski B; Hartley CA; Noormohammadi AH
Infect Genet Evol; 2016 Sep; 43():67-73. PubMed ID: 27223632
[TBL] [Abstract][Full Text] [Related]
39. Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus.
La TM; Choi EJ; Lee JB; Park SY; Song CS; Choi IS; Lee SW
PLoS One; 2019; 14(2):e0211158. PubMed ID: 30730935
[TBL] [Abstract][Full Text] [Related]
40. A practical method for assessing infectious laryngotracheitis vaccine take in broilers following mass administration in water: Spatial and temporal variation in viral genome content of poultry dust after vaccination.
Ahaduzzaman M; Groves PJ; Sharpe SM; Williamson SL; Gao YK; Nguyen TV; Gerber PF; Walkden-Brown SW
Vet Microbiol; 2020 Feb; 241():108545. PubMed ID: 31928697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
